BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3539117)

  • 1. The formation and metabolism of N-hydroxymethyl compounds--IX. N-(acetoxymethyl)-4-chlorobenzamide: an electrophile but not a mutagen in Salmonella typhimurium.
    Overton M; Threadgill MD; Chipman JK; Gescher A; Hickman JA
    Biochem Pharmacol; 1986 Dec; 35(23):4161-5. PubMed ID: 3539117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation of 9-hydroxymethyl-10-methylanthracene and 1-hydroxymethylpyrene to electrophilic, mutagenic and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity.
    Surh YJ; Blomquist JC; Liem A; Miller JA
    Carcinogenesis; 1990 Sep; 11(9):1451-60. PubMed ID: 2205404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formation and metabolism of N-hydroxymethyl compounds--III. The metabolic conversion of N-methyl and N,N,-dimethylbenzamides to N-hydroxymethyl compounds.
    Ross D; Farmer PB; Gescher A; Hickman JA; Threadgill MD
    Biochem Pharmacol; 1983 Jun; 32(11):1773-81. PubMed ID: 6860427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple metabolic pathways for the mutagenic activation of 3-nitrobenzo[a]pyrene.
    Chou MW; Heflich RH; Fu PP
    Carcinogenesis; 1985 Aug; 6(8):1235-8. PubMed ID: 3893788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine inhibits hepatic-microsomal activation of some dietary genotoxins.
    Alldrick AJ; Rowland IR
    Mutagenesis; 1988 Sep; 3(5):423-7. PubMed ID: 3070277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of a stable N-hydroxymethyl derivative of a N-methylamide.
    Ross D; Farmer PB; Gescher A; Hickman JA; Threadgill MD
    Life Sci; 1983 Feb; 32(6):597-604. PubMed ID: 6835025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivation of 5-hydroxymethyl-2-furaldehyde to an electrophilic and mutagenic allylic sulfuric acid ester.
    Lee YC; Shlyankevich M; Jeong HK; Douglas JS; Surh YJ
    Biochem Biophys Res Commun; 1995 Apr; 209(3):996-1002. PubMed ID: 7733994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal metabolism of the food mutagen 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]-quinoxaline to mutagenic metabolites.
    Frandsen H; Nielsen PA; Grivas S; Larsen JC
    Mutagenesis; 1994 Jan; 9(1):59-65. PubMed ID: 8208131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen-dependent renal microsomal cytochrome P-450 responsible for N-hydroxylation and mutagenic activation of 3-methoxy-4-aminoazobenzene in the BALB/c mouse.
    Degawa M; Miura S; Hashimoto Y
    Cancer Res; 1990 May; 50(9):2729-33. PubMed ID: 2328499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfate esters of hydroxymethyl-methyl-benz[a]anthracenes as active metabolites of 7,12-dimethylbenz[a]anthracene.
    Watabe T; Ishizuka T; Fujieda T; Hiratsuka A; Ogura K
    Jpn J Cancer Res; 1985 Aug; 76(8):684-98. PubMed ID: 3930446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding and mutagenicity of 7-substituted derivatives of benz[A]anthracene.
    Wettstein JG; Chien MT; Flesher JW
    Drug Chem Toxicol; 1979; 2(4):383-96. PubMed ID: 396148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of biotransformation of 2,4-dinitrotoluene on its mutagenic potential.
    Couch DB; Abernethy DJ; Allen PF
    Mutagenesis; 1987 Nov; 2(6):415-8. PubMed ID: 3328032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxylation and nitroreduction are required to activate dimethylnitramine into alkylating and mutagenic agents.
    Malaveille C; Croisy A; Brun G; Bartsch H
    Carcinogenesis; 1983 Nov; 4(11):1477-81. PubMed ID: 6357524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and biological properties of prospective N-nitrodialkylamine metabolites and their derivatives.
    Frei E; Pool BL; Plesch W; Wiessler M
    IARC Sci Publ; 1984; (57):491-7. PubMed ID: 6398301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Aminobenzamide: effects on cytochrome P450-dependent metabolism of chemicals and on the toxicity of dichlobenil in the olfactory mucosa.
    Eriksson C; Busk L; Brittebo EB
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):324-31. PubMed ID: 8619240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
    Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
    Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of DNA adducts by the co-mutagen norharman with aromatic amines.
    Mori M; Totsuka Y; Fukutome K; Yoshida T; Sugimura T; Wakabayashi K
    Carcinogenesis; 1996 Jul; 17(7):1499-503. PubMed ID: 8706255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beranek DT; White GL; Heflich RH; Beland FA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation and deactivation of fusarin C, a mutagen produced by Fusarium moniliforme.
    Gelderblom WC; Thiel PG; van der Merwe KJ
    Biochem Pharmacol; 1984 May; 33(10):1601-3. PubMed ID: 6732833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.